{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:23:44Z","timestamp":1791001424644,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biomaterials.2022.121770","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T08:33:03Z","timestamp":1662021183000},"page":"121770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Precise gliomas therapy: Hypoxia-activated prodrugs sensitized by nano-photosensitizers"],"prefix":"10.1016","volume":"289","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saran","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhe","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8806-322X","authenticated-orcid":false,"given":"Xiaojun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2022.121770_bib1","article-title":"Recent progress in the design of hypoxia-specific nano drug delivery systems for cancer therapy","volume":"1","author":"Sahu","year":"2018","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121770_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41588-018-0318-2","article-title":"Molecular landmarks of tumor hypoxia across cancer types","volume":"51","author":"Bhandari","year":"2019","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121770_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","article-title":"What is the evidence that tumors are angiogenesis dependent?","volume":"82","author":"Folkman","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biomaterials.2022.121770_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2017.02.001","article-title":"Mimicking oxygen delivery and waste removal functions of blood","volume":"122","author":"Zhang","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121770_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tibs.2012.06.004","article-title":"Passing the baton: the HIF switch","volume":"37","author":"Koh","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biomaterials.2022.121770_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120847","article-title":"Tumor hypoxia-activated combinatorial nanomedicine triggers systemic antitumor immunity to effectively eradicate advanced breast cancer","volume":"273","author":"Liu","year":"2021","journal-title":"Biomaterials"},{"issue":"46","key":"10.1016\/j.biomaterials.2022.121770_bib7","doi-asserted-by":"crossref","first-page":"15820","DOI":"10.1021\/jacs.8b09117","article-title":"De novo design of phototheranostic sensitizers based on structure-inherent targeting for enhanced cancer ablation","volume":"140","author":"Li","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121770_bib8","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1039\/D0CS00173B","article-title":"Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application","volume":"50","author":"Zhao","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2022.121770_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120537","article-title":"Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors","volume":"268","author":"Fu","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121770_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","article-title":"Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck","volume":"38","author":"Brizel","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121770_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121770_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-4598-2-23","article-title":"Molecular responses to hypoxia in tumor cells","volume":"2","author":"Kunz","year":"2003","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121770_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4161\/auto.5278","article-title":"Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3","volume":"4","author":"Azad","year":"2008","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121770_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121770_bib15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00259-017-3677-5","article-title":"[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis","volume":"44","author":"Bekaert","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121770_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2022.121770_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120533","article-title":"A self-activating nanovesicle with oxygen-depleting capability for efficient hypoxia-responsive chemo-thermo cancer therapy","volume":"269","author":"Chen","year":"2021","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121770_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11426-020-9880-7","article-title":"Hypoxia-activatable nano-prodrug for fluorescently tracking drug release in mice","volume":"64","author":"Li","year":"2021","journal-title":"Sci. China Chem."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121770_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3857\/roj.2016.02012","article-title":"Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy","volume":"34","author":"Hong","year":"2016","journal-title":"Radiat. Oncol. J."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121770_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10637-009-9356-z","article-title":"Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1\/2 activation","volume":"29","author":"Hong","year":"2011","journal-title":"Invest. N. Drugs"},{"issue":"Suppl 5","key":"10.1016\/j.biomaterials.2022.121770_bib21","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/annonc\/10.suppl_5.S29","article-title":"Tirapazamine: a new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancer","volume":"10","author":"Wouters","year":"1999","journal-title":"Ann. Oncol."},{"issue":"18","key":"10.1016\/j.biomaterials.2022.121770_bib22","first-page":"5248","article-title":"Tirapazamine: a hypoxia-activated topoisomerase II Poison1","volume":"62","author":"Peters","year":"2002","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121770_bib23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1021\/tx980184j","article-title":"Direct evidence for bimodal DNA damage induced by tirapazamine","volume":"11","author":"Daniels","year":"1998","journal-title":"Chem. Res. Toxicol."},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121770_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805955","article-title":"Selectively potentiating hypoxia levels by combretastatin A4 nanomedicine: toward highly enhanced hypoxia-activated prodrug tirapazamine therapy for metastatic tumors","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.biomaterials.2022.121770_bib25","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.2005.05.2878","volume":"24","author":"Rischin","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2022.121770_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semcancer.2018.07.006","article-title":"Comparison of glioblastoma (GBM) molecular classification methods","volume":"53","author":"Lee","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biomaterials.2022.121770_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"19","key":"10.1016\/j.biomaterials.2022.121770_bib28","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.7150\/thno.60851","article-title":"Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment","volume":"11","author":"Hong","year":"2021","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.biomaterials.2022.121770_bib29","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1200\/JCO.2017.74.2965","article-title":"Brain tumors: challenges and opportunities to cure","volume":"35","author":"Mellinghoff","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121770_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1172\/JCI40283","article-title":"Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice","volume":"120","author":"Kioi","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121770_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030542","article-title":"The role of hypoxia in glioblastoma radiotherapy resistance","volume":"13","author":"Chedeville","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121770_bib32","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2022.121770_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0940-2993(11)80292-7","article-title":"Vascular morphology and angiogenesis in glial tumors","volume":"47","author":"Plate","year":"1995","journal-title":"Exp. Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121770_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","article-title":"'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis","volume":"65","author":"Rong","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121770_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Jain","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121770_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080339","article-title":"Acute vs. Chronic vs. Cyclic hypoxia: their differential dynamics, molecular mechanisms, and effects on tumor progression","volume":"9","author":"Saxena","year":"2019","journal-title":"Biomolecules"},{"issue":"33","key":"10.1016\/j.biomaterials.2022.121770_bib37","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.biomaterials.2007.06.011","article-title":"Active targeting of brain tumors using nanocarriers","volume":"28","author":"Beduneau","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121770_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121770_bib39","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121770_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.chempr.2021.10.006","article-title":"The concept and examples of type-III photosensitizers for cancer photodynamic therapy","volume":"8","author":"Yao","year":"2022","journal-title":"Chem"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121770_bib41","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1039\/C9CS00129H","article-title":"The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer","volume":"49","author":"Lo","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121770_bib42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11426-021-1179-7","article-title":"Se-sensitized NIR hot band absorption photosensitizer for anti-Stokes excitation deep photodynamic therapy","volume":"65","author":"Ma","year":"2022","journal-title":"Sci. China Chem."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121770_bib43","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/jacs.1c11886","article-title":"ER-targeting cyanine dye as an NIR photoinducer to efficiently trigger photoimmunogenic cancer cell death","volume":"144","author":"Ma","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"28","key":"10.1016\/j.biomaterials.2022.121770_bib44","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.1002\/anie.201500478","article-title":"Hypoxia induced by upconversion-based photodynamic therapy: towards highly effective synergistic bioreductive therapy in tumors","volume":"54","author":"Liu","year":"2015","journal-title":"Angew. Chem., Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121770_bib45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s11426-020-9922-3","article-title":"Radical induced quartet photosensitizers with high 1O2 production for in vivo cancer photodynamic therapy","volume":"64","author":"Xu","year":"2021","journal-title":"Sci. China Chem."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121770_bib46","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s11426-020-9947-4","article-title":"NIR photosensitizers activated by \u03b3-glutamyl transpeptidase for precise tumor fluorescence imaging and photodynamic therapy","volume":"64","author":"Chen","year":"2021","journal-title":"Sci. China Chem."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121770_bib47","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/nnm.13.118","article-title":"Current trends in the use of liposomes for tumor targeting","volume":"8","author":"Deshpande","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2022.121770_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119755","article-title":"Catalase-based liposomal for reversing immunosuppressive tumor microenvironment and enhanced cancer chemo-photodynamic therapy","volume":"233","author":"Shi","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121770_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119666","article-title":"An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy","volume":"230","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"issue":"4826","key":"10.1016\/j.biomaterials.2022.121770_bib50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2821619","article-title":"New perspectives in cell adhesion: RGD and integrins","volume":"238","author":"Ruoslahti","year":"1987","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121770_bib51","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2022.121770_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.biomaterials.2016.07.023","article-title":"iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes","volume":"104","author":"Simon-Gracia","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121770_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2013.10.017","article-title":"Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex","volume":"458","author":"Wang","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121770_bib54","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0271678X16630991","article-title":"In vitro models of the blood-brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use","volume":"36","author":"Helms","year":"2016","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121770_bib55","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/jacs.8b12167","article-title":"In vivo albumin traps photosensitizer monomers from self-assembled phthalocyanine nanovesicles: a facile and switchable theranostic approach","volume":"141","author":"Li","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121770_bib56","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/acsbiomaterials.0c00743","article-title":"Effect of nanoparticle composition, size, shape, and stiffness on penetration across the blood-brain barrier","volume":"6","author":"Brown","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121770_bib57","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1248\/bpb.34.1058","article-title":"Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia","volume":"34","author":"Gong","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"46","key":"10.1016\/j.biomaterials.2022.121770_bib58","doi-asserted-by":"crossref","first-page":"23709","DOI":"10.1039\/D0NR04035E","article-title":"A combination of receptor mediated transcytosis and photothermal effect promotes BBB permeability and the treatment of meningitis using itraconazole","volume":"12","author":"Zhang","year":"2020","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121770_bib59","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.freeradbiomed.2011.05.023","article-title":"Major determinants of photoinduced cell death: Subcellular localization versus photosensitization efficiency","volume":"51","author":"Oliveira","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121770_bib60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10571-015-0204-8","article-title":"Effects of muscone on the expression of P-gp, MMP-9 on blood-brain barrier model in vitro","volume":"35","author":"Wang","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"issue":"23","key":"10.1016\/j.biomaterials.2022.121770_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201808462","article-title":"Linear chimeric triblock molecules self-assembled micelles with controllably transformable property to enhance tumor retention for chemo-photodynamic therapy of breast cancer","volume":"29","author":"Liu","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121770_bib62","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.7150\/thno.41219","article-title":"ATRX\/EZH2 complex epigenetically regulates FADD\/PARP1 axis, contributing to TMZ resistance in glioma","volume":"10","author":"Han","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121770_bib63","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:13:28Z","timestamp":1758906808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222004100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":63,"alternative-id":["S0142961222004100"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121770","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precise gliomas therapy: Hypoxia-activated prodrugs sensitized by nano-photosensitizers","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121770"}}